ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 16

$564K Total Retail Price of All Prescriptions

Rank: 4 out of 16

376 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

10% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 11,357 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 35.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 995 974 1 1
LEVOTHYROXINE SODIUM 543 499 2 6
LISINOPRIL 518 503 3 4
SIMVASTATIN 469 451 4 2
METOPROLOL TARTRATE 388 385 5 8
AMLODIPINE BESYLATE 382 364 6 7
FUROSEMIDE 361 361 7 3
DONEPEZIL HCL 328 328 8 9
MIRTAZAPINE 304 294 9 16
SERTRALINE HCL 289 254 10 10
TRAZODONE HCL 265 237 11 11
CITALOPRAM HBR 236 210 12 12
OMEPRAZOLE 219 207 13 5
HYDROCODONE-ACETAMINOPHEN 211 166 S3 14 15
NAMENDA 189 189 15 18
HYDROCHLOROTHIAZIDE 182 182 16 14
GABAPENTIN 131 109 17 19
METOPROLOL SUCCINATE 125 125 18 23
QUETIAPINE FUMARATE 124 124 19 22
ATORVASTATIN CALCIUM 113 110 20 13
GLIPIZIDE 113 113 20 42
POLYETHYLENE GLYCOL 3350 113 110 20 24
ATENOLOL 109 94 23 17
LANTUS 100 94 24 26
METFORMIN HCL 100 96 24 20
ESCITALOPRAM OXALATE 98 98 26 38
HYDRALAZINE HCL 95 93 27 87
SPIRIVA 92 89 28 31
DIGOXIN 91 90 29 47
CLOPIDOGREL 81 70 30 34
ALENDRONATE SODIUM 79 79 31 25
ENALAPRIL MALEATE 77 71 32 59
CARBIDOPA-LEVODOPA 76 76 33 53
RISPERIDONE 76 52 33 36
ADVAIR DISKUS 75 75 35 39
LEVOFLOXACIN 74 72 36 83
BRIMONIDINE TARTRATE 73 73 37 117
PRAVASTATIN SODIUM 72 72 38 28
TAMSULOSIN HCL 72 65 38 21
ALBUTEROL SULFATE 68 67 40 88
PLAVIX 64 59 41 60
CIPROFLOXACIN HCL 64 62 41 57
LOVASTATIN 63 48 43 44
ALLOPURINOL 62 62 44 29
LATANOPROST 61 61 45 66
ISOSORBIDE MONONITRATE ER 60 60 46 48
DIOVAN 60 60 46 30
LOSARTAN POTASSIUM 59 56 48 27
DILTIAZEM 24HR CD 59 56 48 61
LACTULOSE 58 41 50 74
ZETIA 56 56 51 101
OXYCODONE HCL 54 50 S2 52 37
VENLAFAXINE HCL ER 54 54 52 49
PROAIR HFA 53 52 54 73
OLANZAPINE 53 50 54 72
PANTOPRAZOLE SODIUM 52 51 56 32
FINASTERIDE 51 46 57 54
ENOXAPARIN SODIUM 51 27 57 184
POTASSIUM CHLORIDE 50 50 59 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.